All entries for: HemaNiche Biotech Co., Ltd

January 13, 2026

HemaNiche Biotech Co., Ltd

Orphan Drug Designation

treatment of post-hematopoietic stem cell transplantation thrombocytopenia

Disease Area: Rare Disease
Scroll to Top